Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment
===========================================================================================================================================================================

* Elisabetta Gambale
* Sara Fancelli
* Enrico Caliman
* Maria Cristina Petrella
* Laura Doni
* Serena Pillozzi
* Lorenzo Antonuzzo